Govt To Reduce Prices Of Medical Devices – Mandaviya

Ranchi : On the initiative of Prime Minister Narendra Modi, Centre has taken an initiative to bring down the prices of medical devices by coordinating with various ministries and manufacturers. The Union Minister for Health and Family Welfare, Dr. Mansukh Mandaviya shared this information while replying to a letter of BJP Rajya Sabha MP from State Mahesh Poddar.

Member of Parliament Poddar in his letter written on 23/12/21 has mentioned about relief to the people due to the significant reduction in the prices of cardiac stents and knee implants, at the same time suggesting the Union Health Minister to bring down the prices of other medical devices in dialogue with the manufacturers and various ministries.

Replying to MP Poddar’s letter, Union Health Minister Dr. Mandaviya has said that the National Pharmaceutical Pricing Authority (NPPA) under “Trade Marginalization” has introduced various schemes including Oxygen Concentrator, Glucometer, Nebulizer, Pulse Oximeter, BP Monitor and Digital Thermometer. The prices of other medical devices have been regulated. Further, the NPPA ensures that the MRP of ‘consumables’ notified as drugs is not increased by more than 10% over the price prevailing during the preceding twelve months by their manufacturers.

He informed that comparatively higher duty is levied on medical devices manufactured by the Finance Ministry and lower duty on input goods used in their manufacture to encourage local manufacturing of these items and to create a strong medical device manufacturing sector. Can you

Similarly, the Ministry of Corporate Affairs has made a provision that promotion of health care is prominently included in the ‘Eligible List of Activities’ to be undertaken as CSR by the companies. In addition, setting up of temporary hospitals, temporary COVID care facilities, setting up of medical oxygen production and storage plants, treatment of COVID 19 for persons other than employees and COVID 19 vaccination, manufacture and supply of oxygen concentrators, ventilators, cylinders and other medical equipment.

The Union Health Minister has said in his letter that with these efforts, every effort is being made to make the medical facility affordable for the general public.

  • Related Posts

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    New Delhi: Food regulator FSSAI has suspended the licence of Dior Pharmaceuticals for multiple violations at its nutraceutical factory. In a social media post on Thursday, FSSAI observed “serious non-compliances”…

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Additional chief secretary (ACS), health, Sumita Misra said of these, 12 arrests have been made by FDA, Gurugram, which has also busted multiple interstate counterfeit medicine syndicates, seized fake medicines…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    13 Years after Oxytocin Order, HC Seeks Compilance Status